While current flu shots need to be updated each season, scientists are finding new ways to make vaccine that could last much longer and cover more strains.

The US FDA’s vaccine advisors have recommended that three new influenza strains be included in next winter’s influenza vaccine, aiming in part to tamp down illness caused by subclade K, a mutated form ...

Moderna said it met with the FDA on Tuesday to discuss the vaccine and afterward, the U.S. regulator accepted a revised ...

Although the Centers for Disease Control and Prevention (CDC) classifies the current flu season as “moderate,” at least 90 children have already died of influenza. Among the children who died and were ...

Fact checked by Jennifer Klump For years, researchers have sought to develop a vaccine that can protect against any current ...

With the reversal from the FDA, Moderna said it is aiming to make the vaccine available for the 2026-27 flu season.

WHO announces updated influenza vaccine strains for the 2026–27 northern hemisphere season, reflecting evolving flu virus ...

A long-running debate in vaccine design revolves around whether a vaccine should be optimized to prevent the virus from ...

As flu cases are surging across the United States, here's what to know about whether or not you can still get the vaccine.

Moderna announced that the FDA will review its new mRNA flu vaccine, a reversal less than two weeks after the agency refused to do so. The post FDA to review Moderna's mRNA flu vaccine after initial ...

H3N2, a highly contagious subtype of the influenza A virus, is a formidable respiratory pathogen. It spreads rapidly through airborne droplets, meaning a simple cough, sneeze, or conversation in a ...